SB05 PC is Approved to Conduct Phase III Clinical Trial for Pancreatic Cancer in Israel
SB05 (EndoTAG®-1) is approved to conduct [...]
SB05 PC is Approved to Conduct Phase III Clinical Trial for Pancreatic Cancer in Russia
SB05 (EndoTAG®-1) is approved to conduct Phase III clinical trial [...]
SynCore Biotechnology has Received the Approval to Conduct SB05 PC for Phase III Clinical Trial in South Korea
SB05 (EndoTAG®-1) is approved to conduct Phase III clinical trial in [...]